Clinical Protocols < Clinical Trials as Topic < Clinical Trials, Phase I as Topic

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 36.
[0-20] [0 - 20][0 - 36][20-35][20-40]

Ident.	Authors (with country if any)	Title
000013 (1998)		Ropinirole: new preparation. Wait for more convincing data.
000199 (2000)		Pergolide and Parkinson's disease: new preparation. No clear benefit.
000227 (2001)	O. Rascol [France] ; J. Ferreira ; J L Montastruc	[Abnormal diurnal somnolence, "sleep attacks" and antiparkinson drugs].
000244 (2002)		Clozapine: new preparation. A last resort for parkinsonian patients with psychosis.
000270 (2002)		Selegiline: a second look. Six years later: too risky in Parkinson's disease.
000366 (2003)		Entacapone/levodopa/carbidopa combination tablet: Stalevo.
000439 (2004)	Wassilios Meissner [France] ; Michael P. Hill ; François Tison ; Christian E. Gross ; Erwan Bezard	Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trials.
000502 (2004)	Pierre Cesaro [France]	The Design of Clinical Trials for Cell Transplantation into the Central Nervous System
000517 (2005)		Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
000588 (2006)	Stéphane Thobois [France]	Proposed dose equivalence for rapid switch between dopamine receptor agonists in Parkinson's disease: a review of the literature.
000683 (2006)		Rasagiline. Parkinson's disease: a simple me-too.
000773 (2008)	Grégory Porras [France] ; Erwan Bezard	Preclinical development of gene therapy for Parkinson's disease.
000864 (2008)		Rotigotine: Parkinson's disease: a step backward.
000B24 (2010)	David Devos [France] ; L. Defebvre ; R. Bordet	Dopaminergic and non-dopaminergic pharmacological hypotheses for gait disorders in Parkinson's disease.
000C28 (2010)	Santiago Perez-Lloret [France] ; Olivier Rascol	Dopamine receptor agonists for the treatment of early or advanced Parkinson's disease.
000C97 (2011)	Santiago Perez-Lloret [France] ; Olivier Rascol	Safety of rasagiline for the treatment of Parkinson's disease.
000D11 (2011)	Wassilios G. Meissner [France] ; Mark Frasier ; Thomas Gasser ; Christopher G. Goetz ; Andres Lozano ; Paola Piccini ; José A. Obeso ; Olivier Rascol ; Anthony Schapira ; Valerie Voon ; David M. Weiner ; François Tison ; Erwan Bezard	Priorities in Parkinson's disease research.
000D19 (2011)	Patrice P. Denèfle [France]	Introduction to gene therapy: a clinical aftermath.
000D47 (2011)	Santiago Perez-Lloret [France] ; Santiago Perez Lloret ; María Ver Nica Rey ; Luca Ratti ; Olivier Rascol	Pramipexole for the treatment of early Parkinson's disease.
000D98 (????)	Claire Golé [France] ; Romain Reboul ; Pascale Pisano	[Gene therapy in Parkinson disease: a promising future treatment?].
000E96 (2012)	Santiago Perez-Lloret [France] ; María Ver Nica Rey ; Estelle Dellapina ; Jean Pellaprat ; Christine Brefel-Courbon ; Olivier Rascol	Emerging analgesic drugs for Parkinson's disease.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i -k "Clinical Trials as Topic" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i  \
                -Sk "Clinical Trials as Topic" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Clinical Trials as Topic
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024